# Study of LC23-1306 in Healthy Male Subjects

> **NCT01526577** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 113 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** LC23-1306
- **DRUG:** placebo
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT01526577
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-11
- **Final completion:** 2013-08
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01526577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01526577, "Study of LC23-1306 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01526577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*